Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis

Minerva Cardioangiologica

Volumn 57, Issue 4, 2009, Pages 467-481

  Roldan, C A ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

Author keywords

Antiphospholipid syndrome; Echocardiography; Echocardiography, transesophageal; Lupus erythematosus, systemic

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT;

ANTIPHOSPHOLIPID SYNDROME; BACTERIAL ENDOCARDITIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EMBOLISM; ENDOCARDITIS; HEART VALVE REGURGITATION; HEART VALVE STENOSIS; HUMAN; INTRACARDIAC THROMBOSIS; LIBMAN SACKS EDOCARDITIS; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PSEUDOINFECTION; REVIEW; RHEUMATIC HEART DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; VALVULAR HEART DISEASE; VASCULITIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 70949105751     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Rahman A, Isenberg D. Mechanisms of disease: Systemic lupus erythematosus. N Engl J Med 2008;358:929-939
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763
3. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-686 (Pubitemid 41413291)
4. Tenedios F, Erkan D, Lockshin MD. Cardiac involvement in the antiphospholipid syndrome. Lupus 2005;14:691-696 (Pubitemid 41413293)
5. Omdal R, Lunde P, Rasmussen K, Mellgren SI, Husby G. Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus. Scand J Rheumatol 2001;30:275-281 (Pubitemid 32980340)
6. Lockshin M, Tenedios F, Petri M, McCarty G, Forastiero R, Krilis S et al. Cardiac disease in antiphospholipid syndrome: Recommendations for treatment. Committee consensus report. Lupus 2003;12:518-523
7. Qaddoura F, Connolly H, Grogan M, Orszulak TA, Schaff HV, Chandrasekaran K et al. Valve morphology in the antiphospholipid syndrome: echocardiographic features. Echocardiography 2005;22:255-259 (Pubitemid 40344419)
8. Garcia-Torres R, Amigo MC, de la Rosa A, Moron A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 1996;5:56-61. (Pubitemid 26072430)
9. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 1995;22:1259-1264
10. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. Rheumatol 1997;24:1061-1065
11. Turiel M, Sarzi-Puttini P, Peretti R, Bonizzato S, Muzzupappa S, Atzeni F et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol 2005;96:574-579 (Pubitemid 41132777)
12. Reshetniak TM, Alekberova ZS, Kotel'nikova GP, Aleksandrova EN, Mach ES, Radenska-Lopovok SG et al. Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up. Ter Arkh 2003;75:46-51.
13. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-737
14. Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 2009;62:584-592
15. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis in the antiphospholipid syndrome. Circulation 1996;93:1579- 87.
16. Reisner SA, Brenner B, Haim N, Edoute Y, Markiewicz W. Echocardiography in non-bacterial thrombotic endocarditis: from autopsy to clinical entity. J Am Soc Echocardiogr 2000;13:876-881 (Pubitemid 30743785)
17. Afek A, Shoenfeld Y, Manor R, Goldberg I, Ziporen L, George J et al: Increased endothelial cell expression of alpha3betal integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus 1999;8:502-507 (Pubitemid 29452561)
18. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006;95:94-99
19. Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 2007;6:379-386
20. Roldan CA, Shiveiy BK, Crawford MH. Value of the cardiovascular physical examination for detecting valvular heart disease in asymptomatic subjects. Am J Cardiol 1996;77:1327-1331
21. Joven B, Mellor-Pita S, D'Cruz D, Sharief M, Khamashta M, Hughes GR. Cerebral embolism complicating Libman-Sacks endocarditis full recovery using recombinant tissue plasminogen activator. J Rheumatol 2002;29:2022-2024 (Pubitemid 34988720)
22. Roldan CA, Gelgand EA, Quails CR, Sibbitt WL Jr. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 2005;95:1441-1447
23. Roldan CA, Gelgand EA, Quails CR, Sibbitt WL Jr. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol 2006;12:3-10.
24. Roldan CA, Gelgand EA, Quails CR, Sibbitt WL Jr. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology 2007;108:331-337
25. Krause I, Lev S, Fraser A, Blank M, Lorber M, Stojanovich L et al. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis 2005;64:1490-1493 (Pubitemid 41623863)
26. Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F et al. Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus 2003;12:805-812 (Pubitemid 37463096)
27. Davies JO, Hunt BJ. Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract 2007;61:379-384
28. Nijjar PS, Mountis M, Amanullah AM. Acute myocardial infarction in a patient with systemic lupus erythematosus and normal coronary arteries. Rev Cardiovasc Med 2007;8:36-40. (Pubitemid 46493697)
29. Zurick AO 3rd, Yang EH, Chang PP, Hinderliter AL, Willis PW 4th. A 38-year-old Hispanic woman with paradoxical embolism and Libman-Sacks endocarditis involving the tricuspid valve. J Am Soc Echocardiogr 2007;20:1316.e5-7
30. Schneider C, Bahlmann E, Antz M, Bauer R, Reimers J, Raut W et al. Images in cardiovascular medicine. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosus. Circulation 2003;107:e202-4.
31. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993;46:37-40. (Pubitemid 23039584)
32. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380-384 (Pubitemid 18098245)
33. Perez-Villa F, Font J, Azqueta M, Espinoza G, Pare C, Cervera R et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow-up study. Arthritis Rheum 2005;53:460-467 (Pubitemid 40799888)
34. Takayama T, Teramura M, Sakai H, Tamaki S, Okabayashi T, Kawashima T et al. Perforated mitral valve aneurysm associated with Libman-Sacks endocarditis. Intern Med 2008;47:1605-1608
35. Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997;27:27-35. (Pubitemid 27374246)
36. Fernández-Dueñas J, López-Granados A, Mesa-Rubio D, Ariza-Cañete J, Gallo-Marín M, Concha-Ruiz M. Severe mitral regurgitation in Libman-Sacks endocarditis. Conservative surgery. Rev Esp Cardiol 2005;58:1118-1120 (Pubitemid 41600652)
37. Mehta RK, Agrawal GG, Nanda NC, Tirtaman C, Pacifico A. Flail Aortic valve in systemic lupus erythematosus: diagnosis by transesophageal echocardiography. Echocardiography 1996;13:431-434 (Pubitemid 26257328)
38. Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quinones MA, DeFelice CA et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematosus. J Am Soc Echocardiogr 1996;9:104-107
39. Thomas N, Jesudason M, Mukundan U, John TJ, Seshadri MS, Cherian AM. Infective endocarditis caused by Erysipelothrix rhusiopathiae in a patient with systemic lupus erythematosus. J Assoc Physicians India 1996;44:223. (Pubitemid 126482797)
40. Demin AA, Chapaeva NN, Trifonova MA. Pseudoinfectious endocarditis. Klin Med (Mosk) 2008;86:13-17
41. Yusuf S, Madden BP, Pumhrey CW. Left atrial thrombus caused by the primary antiphospholipid syndrome causing critical functional mitral stenosis. Heart 2002;89:262. (Pubitemid 36241532)
42. Mottram PM, Gelman JS. Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome. J Am Soc Echocardiogr 2002;15:746-748
43. Ebato M, Kitai H, Kumakura H, Nakamura Y, Shimizu N, Takeyama Y. Thrombus on the tricuspid valve in a patient with primary antiphospholipid syndrome after implantation of an inferior vena cava filter. Circ J 2002;66:425-427
44. Mukhopadhyay S, Suryavanshi S, Yusuf J, Chandrashekhar, Rastogi V, Trehan V et al. Isolated thrombus producing tricuspid stenosis: an unusual presentation in primary antiphospholipid syndrome. Indian Heart J 2004;56:61-63 (Pubitemid 38525378)
45. Ghirarduzzi A, Galimberti D, Silingardi M, Cerioli GC, Parravicini R, Salvarani C et al. Left atrial thrombosis in patients with antiphospholipid antibody syndrome and mesenchymal abnormal septum. Ital Heart J Suppl 2001;2:1111-1116 (Pubitemid 33150588)
46. Cervera Miguel JI, Navarro Ibáñez V, Calabuig Muñoz E, Tordera Higón P, Montero Alonso M. Antiphospholipid syndrome. The use of transesophageal echocardiography. An Med Interna 2003;20:532-533
47. O'Neill SG, Woldman S, Bailliard F, Norman W, McEwan J, Isenberg DA et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2008 [Epub ahead of print].
48. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992;20:1127-1134
49. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-1430
50. Zavaleta NE, Montes RM, Soto ME, Vanzzini NA, Amigo MC. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol 2004;31:2402-2407
51. Akins MH, Picard GP, Foster EM, Isselbacher GA, Rose DF, Torchiana CW. Transesophageal Echocardiography Accurate Localization of Mitral Regurgitant Defects Using Multiplane. Ann Thorac Surg 1998;65:1025-1031 (Pubitemid 28212433)
52. Sugeng L, Shernan SK, Weinert L, Shook D, Raman J, Jeevanandam V et al Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr 2008;21:1347-1354
53. Agricola E, Oppizzi M, De Bonis M, Maisano F, Toracca L, Bove T et al. Multiplane transesophageal echocardiography performed according to the guidelines of the American Society of Echocardiography in patients with mitral valve prolapse, flail, and endocarditis: diagnostic accuracy in the identification of mitral regurgitant defects by correlation with surgical findings. J Am Soc Echocardiogr 2003;16:61-66 (Pubitemid 36526621)
54. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802. (Pubitemid 37391035)
55. Roldan CA, Quails CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 2008;35:224-229
56. Omdal R, Lunde P, Rasmussen K, Mellgren SI, Husby G. Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus. Scand J Rheumatol 2001;30:275-281 (Pubitemid 32980340)
57. Kumral E, Evyapan D, Keser G, Kabasakal Y, Oksel F, Aksu K et al. Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 2002;47:131-135 (Pubitemid 34253033)
58. Wolak T, Abu-Shakra M, Flusser D, Liel-Cohen N, Buskila D, Sukenik S. Kingella endocarditis and meningitis in a patient with SLE and associated antiphospholipid syndrome. Lupus 2000;9:393-396 (Pubitemid 30389046)
59. De Castro S, Cartoni D, d'Amati G, Beni S, Yao J, Fiorell M et al. Diagnostic accuracy of transthoracic and multiplane transesophageal echocardiography for valvular perforation in acute infective endocarditis: correlation with anatomic findings. Clin Infect Dis 2000;30:825-826
60. Brito FA, Tófani ML, Tófani FA, Kakehasi AM, Lanna CC, Carvalho MA. Libman-Sacks endocarditis and oral anticoagulation. Arq Bras Cardiol 2004;82:378-383
61. Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W et al. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study. Stroke 2005;36:1490-1494 (Pubitemid 40967518)
62. Kumar S, Sinha B, Ravikumar E. Emergency aortic valve replacement in systemic lupus erythematosus. Heart Lung Circ 2006;15:397-399 (Pubitemid 44817613)
63. Hegde VA, Vivas Y, Shah H, Haybron D, Srinivasan V, Dua A et al. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome a case- series. Heart Lung Circ 2007;16:423-427 (Pubitemid 350091406)
64. Ménard GE. Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 2008;23:883-886
65. Benettoni A, Berton E, De Cunto A, Taddio A, Lepore L. The role of echocardiography in diagnosing carditis in the setting of acute rheumatic fever. Cardiol Young 2009 [Epub ahead of print].
66. Roldan CA, DeLong C, Quails C, Crawford MH. Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates. Am J Cardiol 2007;100:496-502. (Pubitemid 47094699)
67. Roldan CA, Shively BKS, Crawford MH. Valve excrescences: prevalence, evolution, and risk for cardioembolism. J Am Coll Cardiol 1997;30:1308-1314
68. Flachskampf FA. The standard TEE examination: procedure, safety, typical cross-sections and anatomic correlations, and systematic analysis. Semin Cardiothorac Vasc Anesth 2006;10:49-56.
69. Douglas PS, Khanderia B, Stainback RF, Weissman NJ. ACCF/ASE/ACEP/ASNC/ SCAI/SCCT/SCMR 2007 Appropriateness criteria for transthoracic and transesophageal echocardiography. J Am Soc Echocardiogr 2007;21:787-805.